Skip to menu Skip to content Skip to footer
Professor Gabrielle Belz
Professor

Gabrielle Belz

Email: 

Overview

Background

Gabrielle Belz originally trained in veterinary medicine and surgery and received her PhD in understanding the organisation of lymphatics and lymphoid tissues at The University of Queensland. After a short stint in Canada to work on B cells, she moved to St Jude Children’s Research Hospital to work with Peter Doherty supported by an NHMRC CJ Martin Fellowship. Here she established a number of systems that now allow tracking of virus-specific T cells and established the paradigm changing notion that CD4 T cell help was required for generating antiviral responses. She returned to The Walter and Eliza Hall Institute of Medical Research and uncovered the identity of the key dendritic cells necessary for initiating antiviral infections. Subsequently she was awarded the Burnet Prize and NHMRC Elizabeth Blackburn Fellowship. Her research contributions have been recognized by a number of awards including a Wellcome Trust Overseas Fellowship, HHMI international fellowship, ARC Future fellowship, Doctor of Veterinary Science and the Gottschalk Medal (Australian Academy of Science). Her laboratory focuses on deciphering the key cellular and transcriptional signals of protective immunity particularly by T cells and in understanding how innate immune cells develop and make novel contributions to mucosal immune defence.

Availability

Professor Gabrielle Belz is:
Available for supervision

Qualifications

  • Bachelor of Veterinary Biology, The University of Queensland
  • Bachelor (Honours) of Veterinary Science, The University of Queensland
  • Doctor of Philosophy, The University of Queensland
  • Doctoral Diploma, The University of Queensland

Research impacts

Overall goals:

Our work aims to understand how the immune system responds to infections including viruses, bacteria and parasites.

We are elucidating how different types of immune cells develop, and what factors influences their decision to become one type of immune cell or another.

Understanding how the body deals with pathogens will give clues about how to enhance protective immunity. Our goal is to discover new therapies that boost our immune system to protect against infection.

Research interests:

Cell differentiation is the process by which cells develop and mature. In this process, cells become more specialised and acquire potent effector functions that allow them to eliminate infectious organisms. There is an urgent need to develop new therapies that focus on augmenting host immunity.

Our research focuses on:

  • Elucidating the mechanisms responsible for the generation of protective immunity in response to lung and gastrointestinal pathogens
  • How protective immunity breaks down in chronic overwhelming infections
  • Identifying factors that can promote host immune responses and potent long-lived protective immunological memory.

We have developed and use a number of in vivo models of infectious diseases including:

  • Influenza
  • Herpes virus
  • Lymphocytic choriomeningitis virus (LCMV)

These models provide us with an unprecedented opportunity to examine the mechanisms that these pathogens employ to infect hosts and elicit immune protection or to subvert the host responses. Using a variety of approaches including multiparameter flow cytometry, systems biology and global gene expression profiling we aim to define cellular and transcriptional pathways in normal memory T cell differentiation, innate immune cell subsets and immune failure.

Works

Search Professor Gabrielle Belz’s works on UQ eSpace

290 works between 1981 and 2024

1 - 20 of 290 works

2024

Journal Article

Chameleon impersonation of NK cells and ILC1s

Chaudhry, M. Zeeshan and Belz, Gabrielle T. (2024). Chameleon impersonation of NK cells and ILC1s. Nature Immunology, 25 (8), 1-3. doi: 10.1038/s41590-024-01886-x

Chameleon impersonation of NK cells and ILC1s

2024

Journal Article

GFI1B specifies developmental potential of innate lymphoid cell progenitors in the lungs

Huang, Qiutong, H. J. Cao, Wang, Curio, Sophie, Yu, Huiyang, Denman, Renae, Chen, Evelyn, Schreuder, Jaring, Dight, James, Chaudhry, M., Jacquelot, Nicolas, Wimmer, Verena C., Seillet, Cyril, Möröy, Tarik and Belz, Gabrielle T. (2024). GFI1B specifies developmental potential of innate lymphoid cell progenitors in the lungs. Science Immunology, 9 (95) eadj2654, eadj2654. doi: 10.1126/sciimmunol.adj2654

GFI1B specifies developmental potential of innate lymphoid cell progenitors in the lungs

2024

Journal Article

The CD8+ T cell tolerance checkpoint triggers a distinct differentiation state defined by protein translation defects

Van Der Byl, Willem, Nüssing, Simone, Peters, Timothy J., Ahn, Antonio, Li, Hanjie, Ledergor, Guy, David, Eyal, Koh, Andrew S., Wagle, Mayura V., Deguit, Christian Deo T., de Menezes, Maria N., Travers, Avraham, Sampurno, Shienny, Ramsbottom, Kelly M., Li, Rui, Kallies, Axel, Beavis, Paul A., Jungmann, Ralf, Bastings, Maartje M.C., Belz, Gabrielle T., Goel, Shom, Trapani, Joseph A., Crabtree, Gerald R., Chang, Howard Y., Amit, Ido, Goodnow, Chris C., Luciani, Fabio and Parish, Ian A. (2024). The CD8+ T cell tolerance checkpoint triggers a distinct differentiation state defined by protein translation defects. Immunity, 57 (6), 1324-1344.e8. doi: 10.1016/j.immuni.2024.04.026

The CD8+ T cell tolerance checkpoint triggers a distinct differentiation state defined by protein translation defects

2024

Journal Article

Correction to: Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells (Nature Immunology, (2017), 18, 9, (1004-1015), 10.1038/ni.3800)

Gao, Yulong, Souza-Fonseca-Guimaraes, Fernando, Bald, Tobias, Ng, Susanna S., Young, Arabella, Ngiow, Shin Foong, Rautela, Jai, Straube, Jasmin, Waddell, Nic, Blake, Stephen J., Yan, Juming, Bartholin, Laurent, Lee, Jason S., Vivier, Eric, Takeda, Kazuyoshi, Messaoudene, Meriem, Zitvogel, Laurence, Teng, Michele W. L., Belz, Gabrielle T., Engwerda, Christian R., Huntington, Nicholas D., Nakamura, Kyohei, Hölzel, Michael and Smyth, Mark J. (2024). Correction to: Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells (Nature Immunology, (2017), 18, 9, (1004-1015), 10.1038/ni.3800). Nature Immunology, 25 (5), 925-926. doi: 10.1038/s41590-024-01799-9

Correction to: Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells (Nature Immunology, (2017), 18, 9, (1004-1015), 10.1038/ni.3800)

2024

Journal Article

Indirect CD4 <sup>+</sup> T cell protection against mouse gamma-herpesvirus infection via interferon gamma

Xie, Wanxiaojie, Bruce, Kimberley, Belz, Gabrielle T., Farrell, Helen E. and Stevenson, Philip G. (2024). Indirect CD4 + T cell protection against mouse gamma-herpesvirus infection via interferon gamma. Journal of Virology, 98 (5), e0049324. doi: 10.1128/jvi.00493-24

Indirect CD4 <sup>+</sup> T cell protection against mouse gamma-herpesvirus infection via interferon gamma

2024

Conference Publication

TCF-1 is a critical regulator of intraepithelial lymphocytes in colorectal carcinoma

Yakou, Marina H., Ghilas, Sonia, Tran, Kelly, Liao, Yang, Afshar-Sterle, Shoukat, Kumari, Anita, Schmid, Kevin, Dijkstra, Christine, Inguanti, Chantelle, Ostrouska, Simone, Wilcox, Jordan, Smith, Maxine, Parathan, Pavitha, Allam, Amr, Xue, Hai-Hui, Belz, Gabrielle T., Mariadason, John M., Behren, Andreas, Drummond, Grant R., Ruscher, Roland, Williams, David S., Pal, Bhupinder, Shi, Wei, Ernst, Matthias, Raghu, Dinesh and Mielke, Lisa A. (2024). TCF-1 is a critical regulator of intraepithelial lymphocytes in colorectal carcinoma. American Association for Cancer Research Annual Meeting 2024, San Diego, CA United States, 5-10 April 2024. Philadelphia, PA United States: American Association for Cancer Research. doi: 10.1158/1538-7445.am2024-2698

TCF-1 is a critical regulator of intraepithelial lymphocytes in colorectal carcinoma

2024

Journal Article

The transcription factor <scp>SpiB</scp> regulates the fibroblastic reticular cell network and <scp>CD8</scp><sup>+</sup> T‐cell responses in lymph nodes

Horsnell, Harry L, Cao, Wang HJ, Belz, Gabrielle T, Mueller, Scott N and Alexandre, Yannick O (2024). The transcription factor SpiB regulates the fibroblastic reticular cell network and CD8+ T‐cell responses in lymph nodes. Immunology & Cell Biology, 102 (4), 269-279. doi: 10.1111/imcb.12740

The transcription factor <scp>SpiB</scp> regulates the fibroblastic reticular cell network and <scp>CD8</scp><sup>+</sup> T‐cell responses in lymph nodes

2024

Journal Article

In situ single-cell profiling sheds light on IFI27 localisation during SARS-CoV-2 infection

Tan, Chin Wee, Chen, Jinjin, Liu, Ning, Bhuva, Dharmesh D., Blick, Tony, Monkman, James, Cooper, Caroline, Kharbanda, Malvika, Feher, Kristen, Phipson, Belinda, Killingbeck, Emily E., Pan, Liuliu, Kim, Youngmi, Liang, Yan, Nam, Andy, Leon, Michael, Souza-Fonseca-Guimaraes, Paulo, Nagashima, Seigo, Camargo Martins, Ana Paula, Machado-Souza, Cleber, de Noronha, Lucia, Tang, Benjamin, Short, Kirsty, Fraser, John, Belz, Gabrielle T., Souza-Fonseca-Guimaraes, Fernando, Kulasinghe, Arutha and Davis, Melissa J. (2024). In situ single-cell profiling sheds light on IFI27 localisation during SARS-CoV-2 infection. eBioMedicine, 101 105016, 1-4. doi: 10.1016/j.ebiom.2024.105016

In situ single-cell profiling sheds light on IFI27 localisation during SARS-CoV-2 infection

2024

Journal Article

PD-1 regulates ILC3-driven intestinal immunity and homeostasis

Jacquelot, Nicolas, Xiong, Le, Cao, Wang H.J., Huang, Qiutong, Yu, Huiyang, Sayad, Azin, Anttila, Casey J.A., Baldwin, Tracey M., Hickey, Peter F., Amann-Zalcenstein, Daniela, Ohashi, Pamela S., Nutt, Stephen L., Belz, Gabrielle T. and Seillet, Cyril (2024). PD-1 regulates ILC3-driven intestinal immunity and homeostasis. Mucosal Immunology, 17 (3), 371-386. doi: 10.1016/j.mucimm.2024.03.002

PD-1 regulates ILC3-driven intestinal immunity and homeostasis

2024

Journal Article

Faecal microbial transfer and complex carbohydrates mediate protection against COPD

Budden, Kurtis F, Shukla, Shakti D, Bowerman, Kate L, Vaughan, Annalicia, Gellatly, Shaan L, Wood, David L A, Lachner, Nancy, Idrees, Sobia, Rehman, Saima Firdous, Faiz, Alen, Patel, Vyoma K, Donovan, Chantal, Alemao, Charlotte A, Shen, Sj, Amorim, Nadia, Majumder, Rajib, Vanka, Kanth S, Mason, Jazz, Haw, Tatt Jhong, Tillet, Bree, Fricker, Michael, Keely, Simon, Hansbro, Nicole, Belz, Gabrielle T, Horvat, Jay, Ashhurst, Thomas, van Vreden, Caryn, McGuire, Helen, Fazekas de St Groth, Barbara ... Hansbro, Philip M (2024). Faecal microbial transfer and complex carbohydrates mediate protection against COPD. Gut, 73 (5), gutjnl-2023. doi: 10.1136/gutjnl-2023-330521

Faecal microbial transfer and complex carbohydrates mediate protection against COPD

2024

Journal Article

Faster gastrointestinal transit, reduced small intestinal smooth muscle tone and dysmotility in the Nlgn3R451C mouse model of autism

Hosie, Suzanne, Abo-Shaban, Tanya, Mou, Kevin, Balasuriya, Gayathri K., Mohsenipour, Mitra, Alamoudi, Mohammed U., Filippone, Rhiannon T., Belz, Gabrielle T., Franks, Ashley E., Bornstein, Joel C., Nurgali, Kulmira and Hill-Yardin, Elisa L. (2024). Faster gastrointestinal transit, reduced small intestinal smooth muscle tone and dysmotility in the Nlgn3R451C mouse model of autism. International Journal of Molecular Sciences, 25 (2) 832, 1-19. doi: 10.3390/ijms25020832

Faster gastrointestinal transit, reduced small intestinal smooth muscle tone and dysmotility in the Nlgn3R451C mouse model of autism

2024

Journal Article

Unraveling the diversity and functions of tissue-resident plasma cells

Tellier, Julie, Tarasova, Ilariya, Nie, Junli, Smillie, Christopher S., Fedele, Pasquale L., Cao, Wang H. J., Groom, Joanna R., Belz, Gabrielle T., Bhattacharya, Deepta, Smyth, Gordon K. and Nutt, Stephen L. (2024). Unraveling the diversity and functions of tissue-resident plasma cells. Nature Immunology, 25 (2), 330-342+. doi: 10.1038/s41590-023-01712-w

Unraveling the diversity and functions of tissue-resident plasma cells

2024

Journal Article

Whole transcriptome profiling of placental pathobiology in SARS‐CoV‐2 pregnancies identifies placental dysfunction signatures

Stylianou, Nataly, Sebina, Ismail, Matigian, Nicholas, Monkman, James, Doehler, Hadeel, Röhl, Joan, Allenby, Mark, Nam, Andy, Pan, Liuliu, Rockstroh, Anja, Sadeghirad, Habib, Chung, Kimberly, Sobanski, Thais, O'Byrne, Ken, Almeida, Ana Clara Simoes Florido, Rebutini, Patricia Zadorosnei, Machado‐Souza, Cleber, Stonoga, Emanuele Therezinha Schueda, Warkiani, Majid E, Salomon, Carlos, Short, Kirsty, McClements, Lana, de Noronha, Lucia, Huang, Ruby, Belz, Gabrielle T, Souza‐Fonseca‐Guimaraes, Fernando, Clifton, Vicki and Kulasinghe, Arutha (2024). Whole transcriptome profiling of placental pathobiology in SARS‐CoV‐2 pregnancies identifies placental dysfunction signatures. Clinical & Translational Immunology, 13 (2) e1488, e1488. doi: 10.1002/cti2.1488

Whole transcriptome profiling of placental pathobiology in SARS‐CoV‐2 pregnancies identifies placental dysfunction signatures

2023

Journal Article

A centenary of service: 100 years of <i>Immunology &amp; Cell Biology</i>

Liston, Adrian, La Flamme, Anne C, Belz, Gabrielle T, Parish, Christopher R and Greer, Judith M (2023). A centenary of service: 100 years of Immunology &amp; Cell Biology. Immunology & Cell Biology, 101 (10), 882-890. doi: 10.1111/imcb.12700

A centenary of service: 100 years of <i>Immunology &amp; Cell Biology</i>

2023

Journal Article

Survival and division fate programs are preserved but retuned during the naïve to memory CD8<sup>+</sup> T‐cell transition

Heinzel, Susanne, Cheon, HoChan, Belz, Gabrielle T and Hodgkin, Philip D (2023). Survival and division fate programs are preserved but retuned during the naïve to memory CD8+ T‐cell transition. Immunology & Cell Biology, 102 (1), 46-57. doi: 10.1111/imcb.12699

Survival and division fate programs are preserved but retuned during the naïve to memory CD8<sup>+</sup> T‐cell transition

2023

Journal Article

TCF-1 limits intraepithelial lymphocyte antitumor immunity in colorectal carcinoma

Yakou, Marina H., Ghilas, Sonia, Tran, Kelly, Liao, Yang, Afshar-Sterle, Shoukat, Kumari, Anita, Schmid, Kevin, Dijkstra, Christine, Inguanti, Chantelle, Ostrouska, Simone, Wilcox, Jordan, Smith, Maxine, Parathan, Pavitha, Allam, Amr, Xue, Hai-Hui, Belz, Gabrielle T., Mariadason, John M., Behren, Andreas, Drummond, Grant R., Ruscher, Roland, Williams, David S., Pal, Bhupinder, Shi, Wei, Ernst, Matthias, Raghu, Dinesh and Mielke, Lisa A. (2023). TCF-1 limits intraepithelial lymphocyte antitumor immunity in colorectal carcinoma. Science Immunology, 8 (88) eadf2163, eadf2163. doi: 10.1126/sciimmunol.adf2163

TCF-1 limits intraepithelial lymphocyte antitumor immunity in colorectal carcinoma

2023

Conference Publication

High-plex spatial profiling of cutaneous squamous cell carcinoma to identify biomarkers associated with clinical outcomes: The cMIC study

Ladwa, R., Monkman, J., Sadeghirad, H., Cooper, C., Belz, G., Bowman, J., Schaider, H., Liu, H., Kulasinghe, A. and Porceddu, S. (2023). High-plex spatial profiling of cutaneous squamous cell carcinoma to identify biomarkers associated with clinical outcomes: The cMIC study. ESMO Congress 2023, Madrid, Spain, 20-24 October 2023. Amsterdam, Netherlands: Elsevier. doi: 10.1016/j.annonc.2023.09.2278

High-plex spatial profiling of cutaneous squamous cell carcinoma to identify biomarkers associated with clinical outcomes: The cMIC study

2023

Journal Article

The seductive allure of spatial biology: accelerating new discoveries in the life sciences

Kulasinghe, Arutha, Wood, Fiona and Belz, Gabrielle (2023). The seductive allure of spatial biology: accelerating new discoveries in the life sciences. Immunology and Cell Biology, 101 (9), 798-804. doi: 10.1111/imcb.12669

The seductive allure of spatial biology: accelerating new discoveries in the life sciences

2023

Journal Article

A robust platform for integrative spatial multi‐omics analysis to map immune responses to SARS‐CoV‐2 infection in lung tissues

Tan, Xiao, Grice, Laura F., Tran, Minh, Mulay, Onkar, Monkman, James, Blick, Tony, Vo, Tuan, Almeida, Ana Clara, da Silva Motta, Jarbas, Fernandes de Moura, Karen, Machado‐Souza, Cleber, Souza‐Fonseca‐Guimaraes, Paulo, Baena, Cristina Pellegrino, de Noronha, Lucia, Guimaraes, Fernanda Simoes Fortes, Luu, Hung N., Drennon, Tingsheng, Williams, Stephen, Stern, Jacob, Uytingco, Cedric, Pan, Liuliu, Nam, Andy, Cooper, Caroline, Short, Kirsty, Belz, Gabrielle T., Souza‐Fonseca‐Guimaraes, Fernando, Kulasinghe, Arutha and Nguyen, Quan (2023). A robust platform for integrative spatial multi‐omics analysis to map immune responses to SARS‐CoV‐2 infection in lung tissues. Immunology, 170 (3), 401-418. doi: 10.1111/imm.13679

A robust platform for integrative spatial multi‐omics analysis to map immune responses to SARS‐CoV‐2 infection in lung tissues

2023

Journal Article

Innate lymphoid cells: potential targets for cancer therapeutics

Ng, Chun Ki and Belz, Gabrielle T. (2023). Innate lymphoid cells: potential targets for cancer therapeutics. Trends in Cancer, 9 (2), 158-171. doi: 10.1016/j.trecan.2022.10.007

Innate lymphoid cells: potential targets for cancer therapeutics

Funding

Current funding

  • 2025 - 2029
    Unravelling immune signalling networks that protect vertebrates from attack
    ARC Australian Laureate Fellowships
    Open grant
  • 2024 - 2028
    METASPATIAL Study: Metabolic Spatial Analysis of Lung Cancer Study
    NHMRC MRFF EMCR - Early to Mid-Career Researchers
    Open grant
  • 2024 - 2026
    From Pixels to Prognosis: Harnessing single-cell spatial analysis to predict and improve immunotherapy response in lung cancer
    Cure Cancer Early Career Research Grants
    Open grant
  • 2024 - 2026
    Preclinical refinement of a UQ-Moderna vaccine developed to prevent StrepA infection
    NHMRC Development Grant
    Open grant
  • 2024 - 2025
    Screening experimental adjuvants in non-human primates for improved Group A Streptococcus (GAS) vaccine efficacy
    The University of Queensland in America, Inc
    Open grant
  • 2023 - 2026
    Regulation of lung immune-epithelial networks sensing environmental change
    ARC Discovery Projects
    Open grant
  • 2023 - 2028
    Building the next mRNA vaccines and therapies
    MRFF - National Critical Infrastructure Initiative
    Open grant
  • 2023 - 2026
    Personalising Innate-immunotherapy for Superior Treatment Outcomes with Large anticancer applicability (PISTOL)
    NHMRC MRFF EMCR - Early to Mid-Career Researchers
    Open grant
  • 2022 - 2026
    Harnessing immune cell programs to drive immune protection
    NHMRC Investigator Grants
    Open grant
  • 2022 - 2024
    Type 2 innate lymphoid cells orchestrate anti-melanoma responses.
    Cancer Council NSW Project Grant
    Open grant

Past funding

  • 2022 - 2024
    Determining Causative Mechanisms of Hidradenitis Suppurativa (TRI LINC grant led by MSHHS)
    Metro South Hospital and Health Service
    Open grant
  • 2022 - 2024
    LUNG PREDICT Study
    Cancer Australia
    Open grant
  • 2022
    Generating neuroprotective IgA through microbiome-epithelial interactions
    MS Research Australia Project Grant
    Open grant
  • 2021 - 2022
    Cutaneous squamous cell carcinoma and tumour MICroenvironment Multiplex Spatial Profiling - cMIC STUDY (PA Research Foundation Award administered by MSHHS)
    Metro South Hospital and Health Service
    Open grant
  • 2021 - 2023
    Coordinating neuroimmune sensory networks in health and disease
    NHMRC IDEAS Grants
    Open grant
  • 2020 - 2023
    New guardians of the mucosa: Molecular characterisation of M cell biology (ARC Discovery Project administered by UTS)
    University of Technology Sydney
    Open grant
  • 2020 - 2022
    Delineating immune circuits for innate and adaptive immune protection
    NHMRC Research Fellowship
    Open grant
  • 2019 - 2023
    The recirculation of myeloid dendritic cells
    ARC Discovery Projects
    Open grant
  • 2019 - 2021
    Understanding the circadian regulation of the innate lymphoid cells (NHMRC Project Grant administered by WEHI)
    Walter & Eliza Hall Institute of Medical Research (WEHI)
    Open grant

Supervision

Availability

Professor Gabrielle Belz is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Available projects

  • Understanding mucosal immunity

    The picture of the network governing the mucosal immunity and how the different immune populations interplay is only just emerging, but it is already opening a whole new array of exciting possibilities for immune regulation and immunotherapeutic strategies. Our current projects aim to provide a new dimension to this emerging field in understanding how mucosal epithelial cells interact with immune cells to drive mucosal immunosurveillance, homeostasis and immunity. We have developed a number of new tools to dissect this epithelial immune network and understand its regulation in immunity.

  • Delineating long-term protective immunity to pathogen infection

    Our work aims to understand how the immune system responds to infections including viruses, bacteria and parasites. We endeavour to elucidate how different types of immune cells develop, and what factors influences their decision to become one type of immune cell or another. Understanding how the body deals with pathogens will give clues about how to enhance protective immunity. Our goal is to discover new therapies that boost our immune system to protect against infection.

    Our research focuses on:

    • Elucidating the mechanisms responsible for the generation of protective immunity in response to lung and gastrointestinal pathogens including influenza, herpesvirus and intestinal bacterial infections
    • How protective immunity breaks down in chronic overwhelming infections
    • Identifying factors that can promote host immune responses and potent long-lived protective immunological memory

  • Understanding mucosal immunity

    The picture of the network governing the mucosal immunity and how the different immune populations interplay is only just emerging, but it is already opening a whole new array of exciting possibilities for immune regulation and immunotherapeutic strategies. Our current projects aim to provide a new dimension to this emerging field in understanding how mucosal epithelial cells interact with immune cells to drive mucosal immunosurveillance, homeostasis and immunity. We have developed a number of new tools to dissect this epithelial immune network and understand its regulation in immunity.

  • Delineating long-term protective immunity to pathogen infection

    Our work aims to understand how the immune system responds to infections including viruses, bacteria and parasites. We endeavour to elucidate how different types of immune cells develop, and what factors influences their decision to become one type of immune cell or another. Understanding how the body deals with pathogens will give clues about how to enhance protective immunity. Our goal is to discover new therapies that boost our immune system to protect against infection.

    Our research focuses on:

    • Elucidating the mechanisms responsible for the generation of protective immunity in response to lung and gastrointestinal pathogens including influenza, herpesvirus and intestinal bacterial infections
    • How protective immunity breaks down in chronic overwhelming infections
    • Identifying factors that can promote host immune responses and potent long-lived protective immunological memory

  • Unravelling immune signalling networks in mucosal immunity

    Mucosal surfaces are critical interfaces where host-environment interactions occur, and the interplay between epithelial cells and immune components is essential for balancing tolerance and immunity. Disruptions to mucosal barrier integrity have profound consequences, contributing to the onset and progression of numerous diseases. Moreover, mucosal surfaces are key entry points for pathogens, including emerging viral threats, making a robust barrier indispensable for preventing infection. Despite the importance of this barrier, our understanding of how it is regulated and integrates signals from the microbiome to the immune cells is poorly understood.

    This exciting opportunity aims to unravel the intricate interactions between immune cells and epithelial tissues, with a focus on understanding their roles in maintaining barrier integrity and immune homeostasis in mucosal environments such as the gut, lungs, and skin. This project will investigate how epithelial cells communicate with innate and adaptive immune cells to modulate responses to microbial, dietary, and environmental stimuli.

    Utilizing cutting-edge approaches including advanced imaging, organoid co-culture systems, multiomics, and animal models, the candidate will uncover molecular mechanisms that underpin immune-epithelial cross-talk. The findings will unravel new knowledge that sets the foundation for the development of new strategies for diseases such as inflammatory bowel disease, asthma, and other epithelial barrier disorders.

    The Belz Laboratory

    The successful candidate will join a dynamic and interdisciplinary research team in a supportive academic environment. Our team is composed of highly collaborative passionate post-doctoral scientists, research assistants and PhD students with diverse backgrounds. We have expertise in state-of the art imaging, multi-dimensional flow cytometry and mucosal immunology. We provide a unique, collaborative environment and opportunity to develop diverse skill-sets and make impactful discoveries.

    Frazer Institute at the University of Queensland

    The Frazer Institute at the University of Queensland offers a dynamic and collaborative research environment dedicated to advancing biomedical innovation. Situated in Brisbane, a vibrant and rapidly growing hub for science and technology, the Institute provides access to world-class facilities and resources in a stunning subtropical setting.

    As a leading research centre, the Frazer Institute fosters interdisciplinary collaboration, bringing together experts in immunology, molecular biology, and translational medicine. Its strategic partnerships with hospitals, biotech industries, and global research networks enable researchers to translate discoveries into real-world applications.

    The Institute is equipped with state-of-the-art technologies, including single-cell genomics, high-resolution imaging, organoid platforms, and advanced proteomics. These cutting-edge tools empower researchers to explore complex biological questions with unprecedented precision.

    With its emphasis on mentorship, innovation, and impact-driven research, the Frazer Institute offers exceptional opportunities for scientists aiming to contribute to transformative discoveries in health and medicine.

    The Frazer Institute is committed to diversity and equal opportunity and the development of emerging researchers at the highest level.

Supervision history

Current supervision

  • Doctor Philosophy

    Immune Regulation of Lung Injury: Pathways to Repair, Restoration and Fibrosis

    Principal Advisor

    Other advisors: Professor Dan Chambers

  • Doctor Philosophy

    Studying the tumour immune microenvironment in cutaneous squamous cell carcinoma

    Principal Advisor

    Other advisors: Dr Arutha Kulasinghe

  • Doctor Philosophy

    Understanding key epithelial cells in lung infections

    Principal Advisor

    Other advisors: Associate Professor Fernando Guimaraes

  • Doctor Philosophy

    Deciphering the protective program of innate and adaptive cells in pathogen infection

    Principal Advisor

    Other advisors: Dr Timothy Wells

  • Doctor Philosophy

    High Mobility Group Box Family Member TOX2 in Innate Lymphoid Cell Development and Maintenance

    Principal Advisor

    Other advisors: Dr Timothy Wells

  • Doctor Philosophy

    The role of innate cells in shaping the tumour environment.

    Principal Advisor

    Other advisors: Associate Professor Fernando Guimaraes

  • Doctor Philosophy

    Understanding development of an mRNA vaccine to prevent Group A Streptococcus pharyngeal infection

    Principal Advisor

    Other advisors: Professor Mark Walker

  • Doctor Philosophy

    Innate lymphoid cells in tumour control

    Principal Advisor

  • Doctor Philosophy

    Understanding immune diversity in skin inflammation

    Associate Advisor

    Other advisors: Professor Kiarash Khosrotehrani, Dr Snehlata Kumari

  • Doctor Philosophy

    The Ins and Outs of Endocytosis inhibition: Providing diverse opportunities for treatment of incurable cancers

    Associate Advisor

    Other advisors: Dr Shannon Joseph, Associate Professor Fiona Simpson

  • Doctor Philosophy

    Preclinical refinement of a UQ-Moderna vaccine developed to prevent StrepA infection

    Associate Advisor

    Other advisors: Dr Nichaela Harbison-Price, Professor Mark Walker

  • Doctor Philosophy

    Development of natural killer cells with enhanced tumoricidal functions using CRISPR homology-directed repair-mediated gene editing

    Associate Advisor

    Other advisors: Dr Allie Lam, Associate Professor Fernando Guimaraes

Completed supervision

Media

Enquiries

For media enquiries about Professor Gabrielle Belz's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au